Price
¥66,000
Availability (in Japan)
10 or more
(In Japan at 17:00,
Mar 25, 2025 in JST)
Size
200 µL (1 mg/mL)
Data | |||||
---|---|---|---|---|---|
Clonality | Monoclonal | Clone | 6H6 | ||
Isotype (Immunized Animal) | Mouse IgG2aκ | ||||
Applications | |||||
Immunogen (Antigen) | Recombinant full length IGF2BP1 | ||||
Reactivity [Gene ID] | |||||
Storage buffer | 1 mg/mL in PBS/50% glycerol, pH 7.2 | ||||
Storage temp. | -20°C | Conjugate | Unlabeled | Manufacturer | MBL |
Alternative names | insulin-like growth factor binding protein 1, CRD-BP, CRDBP, IMP-1, VICKZ1, ZBP1 | ||||
Background | Localization of IGF2 mRNA-binding protein 1 (IMP1) is associated with motility, and the major functions of IMP1 are carried out by the phylogenetically conserved K homology (KH) domains. IMP1 can affect stability, localization, and translation of its target RNAs. Binding of IMP1 to the leader 3 mRNA in the 5’-untranslated region (UTR) of IGF2 inhibits translation from a leader 3 reporter mRNA. Aberrant IMP1 expression may interfere with c-myc regulation. In tumors, gains at 8q24 (c-myc locus) were observed to be more frequent than those at 17q21 (IMP1 locus). Furthermore, IMP1 expression was frequently detected in tumors, implying that the mechanism of activation is other than that of gene amplification. | ||||
Related products | RN1001 RIP-Assay Kit RN1005 RIP-Assay Kit for microRNA RN007P Anti-IGF2BP1 (IMP1) pAb RN008P Anti-IGF2BP2 (IMP2) pAb RN009P Anti-IGF2BP3 (IMP3) pAb RN048PW Anti-G3BP1 pAb |
||||
Citations |
Western Blotting
|
||||
Product category |
|